HEIDRICH A GRANT III 4
4 · CYTOKINETICS INC · Filed Apr 29, 2004
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
HEIDRICH A GRANT III
Director
Transactions
- Conversion
Series B Preferred Stock
2004-04-28−982,758→ 0 total(indirect: by MF IX)Exercise: $0.00→ Common Stock (982,758 underlying) - Conversion
Series C Preferred Stock
2004-04-28−278,499→ 0 total(indirect: by MF IX)Exercise: $0.00→ Common Stock (278,499 underlying) - Conversion
Series B Preferred Stock
2004-04-28−51,724→ 0 total(indirect: by MF AIV)Exercise: $0.00→ Common Stock (51,724 underlying) - Conversion
Series C Preferred Stock
2004-04-28−14,658→ 0 total(indirect: by MF AIV)Exercise: $0.00→ Common Stock (14,658 underlying) - Conversion
Series A Preferred Stock
2004-04-28−2,317,500→ 0 total(indirect: by MF IX)Exercise: $0.00→ Common Stock (2,317,500 underlying) - Conversion
Series C Preferred Stock
2004-04-28−52,632→ 0 total(indirect: TTEE)Exercise: $0.00→ Common Stock (52,632 underlying) - Conversion
Series E Preferred Stock
2004-04-28−353,961→ 0 total(indirect: by MF IX)Exercise: $0.00→ Common Stock (353,961 underlying) - Conversion
Series E Preferred Stock
2004-04-28−18,629→ 0 total(indirect: by MF AIV)Exercise: $0.00→ Common Stock (18,629 underlying) - Conversion
Common Stock
2004-04-28+98,755→ 98,755 total(indirect: by MFAIV) - Conversion
Series A Preferred Stock
2004-04-28−112,500→ 0 total(indirect: by MF AIV)Exercise: $0.00→ Common Stock (112,500 underlying) - Conversion
Common Stock
2004-04-28+1,876,358→ 1,876,358 total(indirect: by MF IX) - Conversion
Series E Preferred Stock
2004-04-28−5,449→ 0 total(indirect: TTEE)Exercise: $0.00→ Common Stock (5,449 underlying) - Conversion
Common Stock
2004-04-28+29,040→ 29,040 total(indirect: TTEE)
Footnotes (4)
- [F1]The Reporting Person is a Managing Director of Mayfield IX Management, LLC, which is the sole General Partner of each of Mayfield IX (MF IX) and Mayfield Associates Fund IV (MF AIV). The Reporting Person may be deemed to have shared voting and dispositive power over the shares which are or may be deemed to be beneficially owned by MF IX and MF AIV, but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein.
- [F2]The filing of this statement shall not be deemed an admission that, for the purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of equity securities covered by this statement.
- [F3]Upon completion of the initial public offering, all Preferred Stock converted to Common Stock at a ratio of 1-for-2.
- [F4]The Reporting Person is a Trustee of certain family trusts.